Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
The impact of orthostatic challenge on arteriovenous hemodynamics and volume changes of the lower extremity.

Journal of vascular surgery. Venous and lymphatic disorders

Engelberger RP, Keo HH, Blaettler W, Fahrni J, Baumann F, Diehm N, Baumgartner I, Willenberg T.
PMID: 26992583
J Vasc Surg Venous Lymphat Disord. 2013 Jul;1(3):250-6. doi: 10.1016/j.jvsv.2012.12.001. Epub 2013 May 18.

OBJECTIVE: To assess the impact of an orthostatic challenge on arterial and venous hemodynamics and its relation to lower leg volume.METHODS: Hemodynamic parameters of 18 healthy subjects (six men; mean age, 38 ± 11 years) were assessed in the...

Cite
Engelberger RP, Keo HH, Blaettler W, et al. The impact of orthostatic challenge on arteriovenous hemodynamics and volume changes of the lower extremity. J Vasc Surg Venous Lymphat Disord. 2013;1(3):250-6doi: 10.1016/j.jvsv.2012.12.001.
Engelberger, R. P., Keo, H. H., Blaettler, W., Fahrni, J., Baumann, F., Diehm, N., Baumgartner, I., & Willenberg, T. (2013). The impact of orthostatic challenge on arteriovenous hemodynamics and volume changes of the lower extremity. Journal of vascular surgery. Venous and lymphatic disorders, 1(3), 250-6. https://doi.org/10.1016/j.jvsv.2012.12.001
Engelberger, Rolf P, et al. "The impact of orthostatic challenge on arteriovenous hemodynamics and volume changes of the lower extremity." Journal of vascular surgery. Venous and lymphatic disorders vol. 1,3 (2013): 250-6. doi: https://doi.org/10.1016/j.jvsv.2012.12.001
Engelberger RP, Keo HH, Blaettler W, Fahrni J, Baumann F, Diehm N, Baumgartner I, Willenberg T. The impact of orthostatic challenge on arteriovenous hemodynamics and volume changes of the lower extremity. J Vasc Surg Venous Lymphat Disord. 2013 Jul;1(3):250-6. doi: 10.1016/j.jvsv.2012.12.001. Epub 2013 May 18. PMID: 26992583.
Copy Download .nbib Format: NLM
Office workers' objectively assessed total and prolonged sitting time: Individual-level correlates and worksite variations.

Preventive medicine reports

Hadgraft NT, Healy GN, Owen N, Winkler EA, Lynch BM, Sethi P, Eakin EG, Moodie M, LaMontagne AD, Wiesner G, Willenberg L, Dunstan DW.
PMID: 27413681
Prev Med Rep. 2016 Jun 15;4:184-91. doi: 10.1016/j.pmedr.2016.06.011. eCollection 2016 Dec.

Sedentary behavior is highly prevalent in office-based workplaces; however, few studies have assessed the attributes associated with this health risk factor in the workplace setting. This study aimed to identify the correlates of office workers' objectively-assessed total and prolonged...

Cite
Hadgraft NT, Healy GN, Owen N, et al. Office workers' objectively assessed total and prolonged sitting time: Individual-level correlates and worksite variations. Prev Med Rep. 2016;4:184-91doi: 10.1016/j.pmedr.2016.06.011.
Hadgraft, N. T., Healy, G. N., Owen, N., Winkler, E. A., Lynch, B. M., Sethi, P., Eakin, E. G., Moodie, M., LaMontagne, A. D., Wiesner, G., Willenberg, L., & Dunstan, D. W. (2016). Office workers' objectively assessed total and prolonged sitting time: Individual-level correlates and worksite variations. Preventive medicine reports, 4184-91. https://doi.org/10.1016/j.pmedr.2016.06.011
Hadgraft, Nyssa T, et al. "Office workers' objectively assessed total and prolonged sitting time: Individual-level correlates and worksite variations." Preventive medicine reports vol. 4 (2016): 184-91. doi: https://doi.org/10.1016/j.pmedr.2016.06.011
Hadgraft NT, Healy GN, Owen N, Winkler EA, Lynch BM, Sethi P, Eakin EG, Moodie M, LaMontagne AD, Wiesner G, Willenberg L, Dunstan DW. Office workers' objectively assessed total and prolonged sitting time: Individual-level correlates and worksite variations. Prev Med Rep. 2016 Jun 15;4:184-91. doi: 10.1016/j.pmedr.2016.06.011. eCollection 2016 Dec. PMID: 27413681; PMCID: PMC4929063.
Copy Download .nbib Format: NLM
Measurement of the translational and rotational Brownian motion of individual particles in a rarefied gas.

Physical review letters

Blum J, Bruns S, Rademacher D, Voss A, Willenberg B, Krause M.
PMID: 17280186
Phys Rev Lett. 2006 Dec 08;97(23):230601. doi: 10.1103/PhysRevLett.97.230601. Epub 2006 Dec 04.

We measured the free Brownian motion of individual spherical and the Brownian rotation of individual nonspherical micrometer-sized particles in rarefied gas. Measurements were done with high spatial and temporal resolution under microgravity conditions in the Bremen drop tower so...

Cite
Blum J, Bruns S, Rademacher D, et al. Measurement of the translational and rotational Brownian motion of individual particles in a rarefied gas. Phys Rev Lett. 2006;97(23):230601doi: 10.1103/PhysRevLett.97.230601.
Blum, J., Bruns, S., Rademacher, D., Voss, A., Willenberg, B., & Krause, M. (2006). Measurement of the translational and rotational Brownian motion of individual particles in a rarefied gas. Physical review letters, 97(23), 230601. https://doi.org/10.1103/PhysRevLett.97.230601
Blum, Jürgen, et al. "Measurement of the translational and rotational Brownian motion of individual particles in a rarefied gas." Physical review letters vol. 97,23 (2006): 230601. doi: https://doi.org/10.1103/PhysRevLett.97.230601
Blum J, Bruns S, Rademacher D, Voss A, Willenberg B, Krause M. Measurement of the translational and rotational Brownian motion of individual particles in a rarefied gas. Phys Rev Lett. 2006 Dec 08;97(23):230601. doi: 10.1103/PhysRevLett.97.230601. Epub 2006 Dec 04. PMID: 17280186.
Copy Download .nbib Format: NLM
In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model.

Journal of pain research

Nyman E, Franzén B, Nolting A, Klement G, Liu G, Nilsson M, Rosén A, Björk C, Weigelt D, Wollberg P, Karila P, Raboisson P.
PMID: 23403691
J Pain Res. 2013;6:59-70. doi: 10.2147/JPR.S37567. Epub 2013 Jan 30.

AZ465 is a novel selective transient receptor potential cation channel, member A1 (TRPA1) antagonist identified during a focused drug discovery effort. In vitro, AZ465 fully inhibits activation by zinc, O-chlorobenzylidene malononitrile (CS), or cinnamaldehyde of the human TRPA1 channel...

Cite
Nyman E, Franzén B, Nolting A, et al. In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model. J Pain Res. 2013;6:59-70doi: 10.2147/JPR.S37567.
Nyman, E., Franzén, B., Nolting, A., Klement, G., Liu, G., Nilsson, M., Rosén, A., Björk, C., Weigelt, D., Wollberg, P., Karila, P., & Raboisson, P. (2013). In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model. Journal of pain research, 659-70. https://doi.org/10.2147/JPR.S37567
Nyman, Eva, et al. "In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model." Journal of pain research vol. 6 (2013): 59-70. doi: https://doi.org/10.2147/JPR.S37567
Nyman E, Franzén B, Nolting A, Klement G, Liu G, Nilsson M, Rosén A, Björk C, Weigelt D, Wollberg P, Karila P, Raboisson P. In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model. J Pain Res. 2013;6:59-70. doi: 10.2147/JPR.S37567. Epub 2013 Jan 30. PMID: 23403691; PMCID: PMC3565573.
Copy Download .nbib Format: NLM
Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms.

Frontiers in psychiatry

Skule C, Dallavara Lending H, Ulleberg P, Berge T, Egeland J, Landrø NI.
PMID: 24723895
Front Psychiatry. 2014 Mar 27;5:31. doi: 10.3389/fpsyt.2014.00031. eCollection 2014.

Treatment-seeking patients (N = 233) were recruited as they started a course of relapse prevention and coping with depression. The mean Beck depression inventory (BDI-II) score was 26 points, indicating a moderate degree of depression. The sample was recruited...

Cite
Skule C, Dallavara Lending H, Ulleberg P, et al. Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms. Front Psychiatry. 2014;5:31doi: 10.3389/fpsyt.2014.00031.
Skule, C., Dallavara Lending, H., Ulleberg, P., Berge, T., Egeland, J., & Landrø, N. I. (2014). Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms. Frontiers in psychiatry, 531. https://doi.org/10.3389/fpsyt.2014.00031
Skule, Cecilie, et al. "Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms." Frontiers in psychiatry vol. 5 (2014): 31. doi: https://doi.org/10.3389/fpsyt.2014.00031
Skule C, Dallavara Lending H, Ulleberg P, Berge T, Egeland J, Landrø NI. Alcohol Use is Not Directly Related to the Perceived Control of Depressive Symptoms in Patients with Depressive Symptoms. Front Psychiatry. 2014 Mar 27;5:31. doi: 10.3389/fpsyt.2014.00031. eCollection 2014. PMID: 24723895; PMCID: PMC3973897.
Copy Download .nbib Format: NLM
Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight.

Frontiers in physiology

Behringer M, Willberg C.
PMID: 30740059
Front Physiol. 2019 Jan 25;10:33. doi: 10.3389/fphys.2019.00033. eCollection 2019.

In recent years there has been a strong increase in publications on blood flow restriction (BFR) training. In particular, the fact that this type of training requires only low resistance to induce muscle strength and mass gains, makes BFR...

Cite
Behringer M, Willberg C. Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Front Physiol. 2019;10:33doi: 10.3389/fphys.2019.00033.
Behringer, M., & Willberg, C. (2019). Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Frontiers in physiology, 1033. https://doi.org/10.3389/fphys.2019.00033
Behringer, Michael, and Willberg, Christina. "Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight." Frontiers in physiology vol. 10 (2019): 33. doi: https://doi.org/10.3389/fphys.2019.00033
Behringer M, Willberg C. Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Front Physiol. 2019 Jan 25;10:33. doi: 10.3389/fphys.2019.00033. eCollection 2019. PMID: 30740059; PMCID: PMC6355682.
Copy Download .nbib Format: NLM
Editorial: Foot-and-Mouth Disease in Swine.

Frontiers in veterinary science

Perez AM, Willeberg PW.
PMID: 28871286
Front Vet Sci. 2017 Aug 21;4:133. doi: 10.3389/fvets.2017.00133. eCollection 2017.

No abstract available.

Cite
Perez AM, Willeberg PW. Editorial: Foot-and-Mouth Disease in Swine. Front Vet Sci. 2017;4:133doi: 10.3389/fvets.2017.00133.
Perez, A. M., & Willeberg, P. W. (2017). Editorial: Foot-and-Mouth Disease in Swine. Frontiers in veterinary science, 4133. https://doi.org/10.3389/fvets.2017.00133
Perez, Andres M, and Willeberg, Preben W. "Editorial: Foot-and-Mouth Disease in Swine." Frontiers in veterinary science vol. 4 (2017): 133. doi: https://doi.org/10.3389/fvets.2017.00133
Perez AM, Willeberg PW. Editorial: Foot-and-Mouth Disease in Swine. Front Vet Sci. 2017 Aug 21;4:133. doi: 10.3389/fvets.2017.00133. eCollection 2017. PMID: 28871286; PMCID: PMC5572059.
Copy Download .nbib Format: NLM
Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight.

Frontiers in physiology

Behringer M, Willberg C.
PMID: 30984012
Front Physiol. 2019 Mar 26;10:276. doi: 10.3389/fphys.2019.00276. eCollection 2019.

[This corrects the article DOI: 10.3389/fphys.2019.00033.].

Cite
Behringer M, Willberg C. Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Front Physiol. 2019;10:276doi: 10.3389/fphys.2019.00276.
Behringer, M., & Willberg, C. (2019). Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Frontiers in physiology, 10276. https://doi.org/10.3389/fphys.2019.00276
Behringer, Michael, and Willberg, Christina. "Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight." Frontiers in physiology vol. 10 (2019): 276. doi: https://doi.org/10.3389/fphys.2019.00276
Behringer M, Willberg C. Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight. Front Physiol. 2019 Mar 26;10:276. doi: 10.3389/fphys.2019.00276. eCollection 2019. PMID: 30984012; PMCID: PMC6447999.
Copy Download .nbib Format: NLM
Avian influenza overview November 2017 - February 2018.

EFSA journal. European Food Safety Authority

, Adlhoch C, Brouwer A, Kuiken T, Mulatti P, Smietanka K, Staubach C, Willeberg P, Barrucci F, Verdonck F, Amato L, Baldinelli F.
PMID: 32625858
EFSA J. 2018 Mar 28;16(3):e05240. doi: 10.2903/j.efsa.2018.5240. eCollection 2018 Mar.

Between 16 November 2017 and 15 February 2018, one highly pathogenic avian influenza (HPAI) A(H5N6) and five HPAI A(H5N8) outbreaks in poultry holdings, two HPAI A(H5N6) outbreaks in captive birds and 22 HPAI A(H5N6) wild bird events were reported...

Cite
, et al. Avian influenza overview November 2017 - February 2018. EFSA J. 2018;16(3):e05240doi: 10.2903/j.efsa.2018.5240.
, Adlhoch, C., Brouwer, A., Kuiken, T., Mulatti, P., Smietanka, K., Staubach, C., Willeberg, P., Barrucci, F., Verdonck, F., Amato, L., & Baldinelli, F. (2018). Avian influenza overview November 2017 - February 2018. EFSA journal. European Food Safety Authority, 16(3), e05240. https://doi.org/10.2903/j.efsa.2018.5240
"Avian influenza overview November 2017 - February 2018." EFSA journal. European Food Safety Authority vol. 16,3 (2018): e05240. doi: https://doi.org/10.2903/j.efsa.2018.5240
, Adlhoch C, Brouwer A, Kuiken T, Mulatti P, Smietanka K, Staubach C, Willeberg P, Barrucci F, Verdonck F, Amato L, Baldinelli F. Avian influenza overview November 2017 - February 2018. EFSA J. 2018 Mar 28;16(3):e05240. doi: 10.2903/j.efsa.2018.5240. eCollection 2018 Mar. PMID: 32625858; PMCID: PMC7009675.
Copy Download .nbib Format: NLM
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease.

EFSA journal. European Food Safety Authority

, More S, Bøtner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortázar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke HH, Velarde A, Willeberg P, Winckler C, Baldinelli F, Broglia A, Beltrán Beck B, Kohnle L, Morgado J, Bicout D.
PMID: 32625553
EFSA J. 2017 Jul 18;15(7):e04888. doi: 10.2903/j.efsa.2017.4888. eCollection 2017 Jul.

Aujeszky's disease has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on the eligibility of Aujeszky's disease to be listed, Article 9...

Cite
, More S, Bøtner A, et al. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease. EFSA J. 2017;15(7):e04888doi: 10.2903/j.efsa.2017.4888.
, More, S., Bøtner, A., Butterworth, A., Calistri, P., Depner, K., Edwards, S., Garin-Bastuji, B., Good, M., Gortázar Schmidt, C., Michel, V., Miranda, M. A., Nielsen, S. S., Raj, M., Sihvonen, L., Spoolder, H., Stegeman, J. A., Thulke, H. H., Velarde, A., Willeberg, P., Winckler, C., Baldinelli, F., Broglia, A., Beltrán Beck, B., Kohnle, L., Morgado, J., & Bicout, D. (2017). Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease. EFSA journal. European Food Safety Authority, 15(7), e04888. https://doi.org/10.2903/j.efsa.2017.4888
, et al. "Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease." EFSA journal. European Food Safety Authority vol. 15,7 (2017): e04888. doi: https://doi.org/10.2903/j.efsa.2017.4888
, More S, Bøtner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortázar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke HH, Velarde A, Willeberg P, Winckler C, Baldinelli F, Broglia A, Beltrán Beck B, Kohnle L, Morgado J, Bicout D. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease. EFSA J. 2017 Jul 18;15(7):e04888. doi: 10.2903/j.efsa.2017.4888. eCollection 2017 Jul. PMID: 32625553; PMCID: PMC7009985.
Copy Download .nbib Format: NLM
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease.

EFSA journal. European Food Safety Authority

, More S, Bøtner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortázar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke HH, Velarde A, Willeberg P, Winckler C, Baldinelli F, Broglia A, Beltrán Beck B, Kohnle L, Morgado J, Bicout D.
PMID: 32625555
EFSA J. 2017 Jul 18;15(7):e04890. doi: 10.2903/j.efsa.2017.4890. eCollection 2017 Jul.

Ebola virus disease has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on the eligibility of Ebola virus disease to be listed,...

Cite
, More S, Bøtner A, et al. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease. EFSA J. 2017;15(7):e04890doi: 10.2903/j.efsa.2017.4890.
, More, S., Bøtner, A., Butterworth, A., Calistri, P., Depner, K., Edwards, S., Garin-Bastuji, B., Good, M., Gortázar Schmidt, C., Michel, V., Miranda, M. A., Nielsen, S. S., Raj, M., Sihvonen, L., Spoolder, H., Stegeman, J. A., Thulke, H. H., Velarde, A., Willeberg, P., Winckler, C., Baldinelli, F., Broglia, A., Beltrán Beck, B., Kohnle, L., Morgado, J., & Bicout, D. (2017). Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease. EFSA journal. European Food Safety Authority, 15(7), e04890. https://doi.org/10.2903/j.efsa.2017.4890
, et al. "Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease." EFSA journal. European Food Safety Authority vol. 15,7 (2017): e04890. doi: https://doi.org/10.2903/j.efsa.2017.4890
, More S, Bøtner A, Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortázar Schmidt C, Michel V, Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke HH, Velarde A, Willeberg P, Winckler C, Baldinelli F, Broglia A, Beltrán Beck B, Kohnle L, Morgado J, Bicout D. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease. EFSA J. 2017 Jul 18;15(7):e04890. doi: 10.2903/j.efsa.2017.4890. eCollection 2017 Jul. PMID: 32625555; PMCID: PMC7009972.
Copy Download .nbib Format: NLM
Characterization of Phenolic Compounds Extracted from Cold Pressed Cactus (.

Foods (Basel, Switzerland)

Chbani M, Matthäus B, Charrouf Z, El Monfalouti H, Kartah B, Gharby S, Willenberg I.
PMID: 32796773
Foods. 2020 Aug 11;9(8). doi: 10.3390/foods9081098.

Phenolic compounds extracted from cactus seed oil were identified for the first time by HPLC-ESI-qToF-MS and subsequently quantified by HPLC-DAD. A total of 7 compounds were identified, vanillin, syringaldehyde, and ferulaldehyde were found to be the most abundant ones....

Cite
Chbani M, Matthäus B, Charrouf Z, et al. Characterization of Phenolic Compounds Extracted from Cold Pressed Cactus (. Foods. 2020;9(8)doi: 10.3390/foods9081098.
Chbani, M., Matthäus, B., Charrouf, Z., El Monfalouti, H., Kartah, B., Gharby, S., & Willenberg, I. (2020). Characterization of Phenolic Compounds Extracted from Cold Pressed Cactus (. Foods (Basel, Switzerland), 9(8), . https://doi.org/10.3390/foods9081098
Chbani, Malika, et al. "Characterization of Phenolic Compounds Extracted from Cold Pressed Cactus (." Foods (Basel, Switzerland) vol. 9,8 (2020). doi: https://doi.org/10.3390/foods9081098
Chbani M, Matthäus B, Charrouf Z, El Monfalouti H, Kartah B, Gharby S, Willenberg I. Characterization of Phenolic Compounds Extracted from Cold Pressed Cactus (. Foods. 2020 Aug 11;9(8). doi: 10.3390/foods9081098. PMID: 32796773; PMCID: PMC7465185.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries